Prognostic scoring systems for risk assessment in myelodysplastic syndromes

FORUM - Trends in Experimental and Clinical Medicine

Volumn 9, Issue 1, 1999, Pages 17-31

  Greenberg, P L ^a   Sanz, G F ^a   Sanz, M A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chromosomal abnormalities; Myelodysplastic syndromes; Prognosis; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE;

AGE; BONE MARROW; CANCER CLASSIFICATION; CANCER SURVIVAL; CYTOGENETICS; CYTOPENIA; HUMAN; LEUKEMIA; MYELODYSPLASTIC SYNDROME; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; TREATMENT PLANNING;

AGE FACTORS; FEMALE; HUMANS; KARYOTYPING; MALE; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0032916809     PISSN: 11218142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)